Single nucleotide polymorphism analysis of the peroxisome proliferator-activated receptor gamma gene in type 2 diabetes mellitus patients at Ministry of Defense Hospital, RSPPN Soedirman Jakarta
DOI:
https://doi.org/10.58524/app.sci.def.v3i2.830Keywords:
C161T, Nanopore sequencing, PPAR-γ Gene, SNP, Type 2 diabetes mellitusAbstract
Type 2 diabetes mellitus is a metabolic disorder influenced by genetic and environmental factors. The Peroxisome Proliferator-Activated Receptor Gamma gene is known to play a role in T2DM pathogenesis, but its polymorphism profile in Indonesian patients remains poorly characterized. This study aimed to analyze single nucleotide polymorphisms in the PPAR-γ gene of T2DM patients at Rumah Sakit Pusat Pertahanan Negara (RSPPN) Soedirman Jakarta using adaptive sampling with nanopore sequencing. Eighteen DNA samples that passed quality control were analyzed using UGENE v52.1. A total of 26 SNPs were identified in 8 subjects, including C161T, which has a reported protective effect in T2DM. The clinical significance of the remaining SNPs remains unclear. This study provides initial insights into genetic variation in T2DM, which may contribute to personalized medical strategies for military personnel and support the development of a more resilient national defense health system by improving disease prevention and management in high-risk populations.
References
Anderson, C., Macpherson, H., Gustavsson, E., Lee, J., & Chen, zhongbo. (2023). Native Barcoding (SQK-NBD114) gDNA for Adaptive Sampling using Oxford Nanopore Technologies v1. https://doi.org/10.17504/protocols.io.kxygx3qx4g8j/v1
Baynest, H. W. (2015). Classification, Pathophysiology, Diagnosis and Management of Diabetes Mellitus. Journal of Diabetes & Metabolism, 06(05). https://doi.org/10.4172/2155-6156.1000541
Chen, J., & Xu, F. (2023). Application of Nanopore Sequencing in the Diagnosis and Treatment of Pulmonary Infections. In Molecular Diagnosis and Therapy (Vol. 27, Issue 6, pp. 685–701). Adis.
https://doi.org/10.1007/s40291-023-00669-8
Choi, S. S., Park, J., & Choi, J. H. (2014). Revisiting PPARγ as a target for the treatment of metabolic disorders. BMB Reports, 47(11), 599–608. https://doi.org/10.5483/BMBRep.2014.47.11.174
ClinVar. (2025). Database Clinical Variation.
https://www.ncbi.nlm.nih.gov/clinvar/?term=%22PPARG%22%5BGENE%5D&redir=gene
dbSNP. (2025). Database Single Nucleotide Polymorphism.
https://www.ncbi.nlm.nih.gov/snp/?term=PPARG
De Graaff, L. C. G., Van Schaik, R. H. N., & Van Gelder, T. (2013). A clinical approach to pharmacogenetics. Netherlands Journal of Medicine, 71(3), 145–152.
Decroli, E. (2019). Diabetes melitus tipe 2 (A. Kam, Y. P. Efendi, G. P. Decroli, & A. Rahmadi, Eds.). Pusat Penerbitan Bagian Ilmu Penyakit Dalam Fakultas Kedokteran Universitas Andalas.
Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C. (2020). Pathophysiology of Type 2 Diabetes Mellitus. International Journal of Molecular Sciences, 21(17), 6275. https://doi.org/10.3390/ijms21176275
Huang, L.-H., Lin, P.-H., Tsai, K.-W., Wang, L.-J., Huang, Y.-H., Kuo, H.-C., & Li, S.-C. (2017). The effects of storage temperature and duration of blood samples on DNA and RNA qualities. PLOS ONE, 12(9), e0184692. https://doi.org/10.1371/journal.pone.0184692
IDF. (2021). International Diabetes Federation. In Diabetes Research and Clinical Practice (10th Edition, Vol. 102, Issue 2). https://doi.org/10.1016/j.diabres.2013.10.013
Irham, L. M., Dania, H., Maliza, R., Faridah, I. N., & Perwitasari, D. A. (2022). Farmakogenetik-Farmakogenomik: Menuju Precision Medicine (B. A. Afwan, Ed.). UAD PRESS.
Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014). Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. The Lancet, 383(9922), 1068–1083.
https://doi.org/10.1016/S0140-6736(13)62154-6
Kemenkes. (2023). Prevalensi, Dampak, Serta Upaya Pengendalian Hipertensi dan Diabetes di Indonesia.
Li, S., He, C., Nie, H., Pang, Q., Wang, R., Zeng, Z., & Song, Y. (2022). G Allele of the rs1801282 Polymorphism in PPARγ Gene Confers an Increased Risk of Obesity and Hypercholesterolemia, While T Allele of the rs3856806 Polymorphism Displays a Protective Role Against Dyslipidemia: A Systematic Review and Meta-Analysis. Frontiers in Endocrinology, 13.
https://doi.org/10.3389/fendo.2022.919087
Lin, B., Hui, J., & Mao, H. (2021). Nanopore technology and its applications in gene sequencing. Biosensors, 11(7). https://doi.org/10.3390/bios11070214
Miga, K. H., Koren, S., Rhie, A., Vollger, M. R., Gershman, A., Bzikadze, A., Brooks, S., Howe, E., Porubsky, D., Logsdon, G. A., Schneider, V. A., Potapova, T., Wood, J., Chow, W., Armstrong, J., Fredrickson, J., Pak, E., Tigyi, K., Kremitzki, M., … Phillippy, A. M. (2020). Telomere-to-telomere assembly of a complete human X chromosome. Nature, 585(7823), 79–84. https://doi.org/10.1038/s41586-020-2547-7
Okonechnikov, K., Golosova, O., & Fursov, M. (2012). Unipro UGENE: a unified bioinformatics toolkit. Bioinformatics, 28(8), 1166–1167. https://doi.org/10.1093/bioinformatics/bts091
PE Indonesia. (2021). Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia 2021. In PB Perkeni.
Sapra, A., & Bhandari, P. (2023). Diabetes. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK551501/
Sarhangi, N., Sharifi, F., Hashemian, L., Hassani Doabsari, M., Heshmatzad, K., Rahbaran, M., Jamaldini, S. H., Aghaei Meybodi, H. R., & Hasanzad, M. (2020). PPARG (Pro12Ala) genetic variant and risk of T2DM: a systematic review and meta-analysis. Scientific Reports, 10(1), 12764.
https://doi.org/10.1038/S41598-020-69363-7
Tiongco, R. E., Basilio, H., Camacho, D. R., Ellorin, W. M., Sico, C. A., & Arceo, E. (2023). Association of the rs3856806 Polymorphism in the PPARG Gene with Type 2 Diabetes Mellitus: A Meta-Analysis of 11,811 Individuals. Laboratory Medicine, 54(2), 193–198.
https://doi.org/10.1093/labmed/lmac095
Wetterstrand, K. A. (2024). Nanopore DNA Sequencing. National Genome Human Research Institute. https://www.genome.gov/genetics-glossary/Nanopore-DNA-Sequencing
WHO. (2016). Global Report on Diabetes. World Health Organization.
Zheng, Y., Ley, S. H., & Hu, F. B. (2018). Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. In Nature Reviews Endocrinology (Vol. 14, Issue 2, pp. 88–98). Nature Publishing Group. https://doi.org/10.1038/nrendo.2017.151
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Luluk Sakdiyyah, Apip Hadi, Yustinus Maladan, Syahrul Tuba

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.